Microfluidic Digital Holography for Red Blood Cell Deformability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic methods for hematologic diseases, such as sickle cell disease, lack objective measures and rely heavily on subjective patient-reported symptoms, making frequent severity monitoring challenging, especially in resource-limited settings.

Innovation Solution

A system utilizing microfluidic channels with cross-sectional dimensions smaller than a red blood cell's thickness, combined with an inline digital holography technique, to deform and analyze red blood cells, providing quantitative characterization of deformability and severity of hematologic diseases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional diagnostic methods are used for hematologic diseases, then the diagnostic process is simple, but the measurement precision and objectivity are insufficient due to reliance on subjective patient-reported symptoms

Engineering Contradiction:
Improvedeformability measurement precisionVSAvoidsystem complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system segments the complex diagnostic task into distinct functional modules: microfluidic channels for cell deformation, digital holography imaging for capture, and image processing algorithms for quantification. Each module handles a specific aspect of the measurement, enabling high precision while managing overall system complexity through modular design

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Digital holography serves as an intermediary technique that bridges the gap between simple observation and complex analysis. It captures three-dimensional information of deforming red blood cells without requiring direct mechanical contact or complex sensing apparatus, thereby achieving high measurement precision with relatively simple implementation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If frequent severity monitoring is implemented, then the disease state tracking is improved, but the operational complexity increases due to lack of objective measures and reliance on subjective symptoms

Engineering Contradiction:
Improvedisease state assessment reliabilityVSAvoidmonitoring ease of operation
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The system enables self-service monitoring where the objective measurement is automatically obtained through the microfluidic-digital holography apparatus. The deformability parameters are directly measured and quantified without requiring skilled interpretation of subjective symptoms, making frequent monitoring reliable and operationally simple

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system transforms the abstract concept of disease severity into concrete, quantifiable parameters such as deformability index, transit time, and shape factors. These objective parameters can be frequently measured and tracked, improving reliability while simplifying the monitoring process through automated parameter extraction

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If microfluidic channels with cross-sectional dimension smaller than red blood cell thickness are used, then the deformability measurement accuracy is improved, but the device complexity and manufacturing difficulty increase

Engineering Contradiction:
Improvechannel dimension precisionVSAvoidmicrofluidic channel manufacture
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The system uses digital holography to capture three-dimensional information of red blood cells as they deform through the microfluidic channel. This dimensional approach allows accurate measurement of deformability without requiring extremely precise control of channel dimensions, as the measurement is derived from the cell's three-dimensional deformation pattern rather than strict geometric constraints

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

4Productivity

If digital holography technique is implemented for real-time imaging, then the measurement speed and accuracy are improved, but the energy consumption and system complexity increase

Engineering Contradiction:
Improvemeasurement speedVSAvoidimaging energy consumption
Core Design Contradiction:
ProductivityVSUse of energy by moving object

Solution Approach 1:

The system replaces mechanical imaging systems with digital holography, which uses optical fields instead of mechanical scanning or moving parts. This substitution enables rapid capture of deformation dynamics without the energy consumption associated with mechanical actuators or high-power illumination, achieving high measurement speed with moderate energy usage

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables objective and accurate measurement of red blood cell deformability, allowing for the determination of hematologic disease severity and health status reporting, potentially improving diagnosis and treatment monitoring.

Implementation Method 1

The one or more microfluidic channels with the at least one cross-sectional dimension is configured to deform red blood cells of a blood sample that flow through the one or more microfluidic channels

Methodology Applied
Scientific EffectMechanical deformation: Deformation

Implementation Method 2

at least one imager is configured to generate a sequence of digital holography images or videos of the red blood cells of the blood sample that flow through the one or more microfluidic channels

Methodology Applied
Scientific EffectDigital holography: Interference

Data Source

PatentUS20250198897A1Systems, apparatuses, and methods to measure deformability of red blood cells in microfluidic channels
Publication Date: 2025.06.19 HONEYWELL INTERNATIONAL INC
  • US20250198897A1 patent drawing
  • US20250198897A1 patent drawing
  • US20250198897A1 patent drawing

AI summary

A system and a method for measuring deformability of red blood cells in microfluidic channels are disclosed. The system comprises one or more devices having one or more microfluidic channels with at least one cross-sectional dimension and configured to allow deformation of red blood cells of a blood sample to flow through the one or more microfluidic channels. Further, at least one imager is configured to generate a sequence of digital holography images or videos of the red blood cells of the blood sample transiting through the one or more microfluidic channels. Further, the system includes at least one processor that is operationally coupled to the at least one imager. The at least one processor is configured to analyze the generated sequence of digital holography images or videos to quantify and characterize deformability of the red blood cells within the one or more microfluidic channels.